Amanote Research

Amanote Research

    RegisterSign In

Safety of Apixaban for Venous Thromboembolism Prophylaxis: The Evidence to Date

Drug, Healthcare and Patient Safety - New Zealand
doi 10.2147/dhps.s74410
Full Text
Open PDF
Abstract

Available in full text

Categories
Health PolicyPharmacology
Date

February 1, 2016

Authors
Vladimir Trkulja
Publisher

Informa UK Limited


Related search

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2014English

3 Venous Thromboembolism Prophylaxis

2019English

Process Improvement in Prophylaxis for Venous Thromboembolism

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Venous Thromboembolism Prophylaxis, or Lack of …

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1995English

Updates on Prophylaxis for Deep Venous Thrombosis and Venous Thromboembolism

Medical Research Archives
2019English

Venous Thromboembolism Prophylaxis in Arthroscopic Surgery

Ortopedia Traumatologia Rehabilitacja
OrthopedicsSports MedicineRehabilitation
2013English

Cost Effectiveness of Prophylaxis of Venous Thromboembolism

Journal of the Royal Society of Medicine
Medicine
1981English

Venous Thromboembolism Prophylaxis in Cancer Patients

2012English

Budget Impact Analysis of Apixaban to Treat and Prevent Venous Thromboembolism in Italy

Farmeconomia. Health economics and therapeutic pathways
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy